Safety evaluation of the food enzyme bacillolysin from the non‐genetically modified Bacillus amyloliquefaciens strain BP Authors: EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L M Solano, Henk Van Loveren, Laurence Vernis, Simone Lunardi, Magdalena Andryszkiewicz, Daniele Cavanna, Ana Criado, Yi Liu Published: 2026 ABSTRACT AbstractThe food enzyme bacillolysin (EC 3.4.24.28) is produced with the non‐genetically modified Bacillus amyloliquefaciens strain BP by HBI Enzymes Inc. The food enzyme is intended to be used in eight food manufacturing processes. Since residual amounts of total organic solids (TOS) are removed in one process, dietary exposure was calculated for the remaining seven food manufacturing processes. It was estimated to be up to 1.249 mg TOS/kg body weight per day in European populations. As the production strain qualifies for the Qualified Presumption of Safety approach to safety assessment and no issues of concern arising from the production process of the food enzyme were identified, the Panel considered that no toxicological studies other than the assessment of allergenicity were necessary. A search for the homology of the amino acid sequence of the bacillolysin to known allergens was made, and a match with one respiratory allergen was found. The Panel considered that a risk of allergic reactions upon dietary exposure to the food enzyme cannot be excluded. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.Keywords: bacillolysin, Bacillus amyloliquefaciens, Bacillus metalloendopeptidase, EC 3.4.24.28, EFSA‐Q‐2022‐00517, food enzyme INTRODUCTION Article 3 of the Regulation (EC) No 1332/2008 1 provides definition for ‘food enzyme’ and ‘food enzyme preparation’. ‘Food enzyme’ means a product obtained from plants, animals or microorganisms or products thereof including a product obtained by a fermentation process using microorganisms: (i) containing one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a technological purpose at any stage of the manufacturing, processing, preparation, treatment, packaging, transport or storage of foods. ‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which substances such as food additives and/or other food ingredients are incorporated to facilitate their storage, sale, standardisation, dilution or dissolution. Before January 2009, food enzymes other than those used as food additives were not regulated or were regulated as processing aids under the legislation of the Member States. On 20 January 2009, Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes that are added to food to perform a technological function in the manufacture, processing, preparation, treatment, packaging, transport or storage of such food, including enzymes used as processing aids. Regulation (EC) No 1331/2008 2 established the European Union (EU) procedures for the safety assessment and the authorisation procedure of food additives, food enzymes and food flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that: it does not pose a safety concern to the health of the consumer at the level of use proposed; it does not pose a safety concern to the health of the consumer at the level of use proposed; there is a reasonable technological need; there is a reasonable technological need; its use does not mislead the consumer. its use does not mislead the consumer. All food enzymes currently on the EU market and intended to remain on that market, as well as all new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority (EFSA) and approval via an EU Community list. Background and Terms of Reference as provided by the requestor Background as provided by the European Commission Only food enzymes included in the Union list may be placed on the market as such and used in foods, in accordance with the specifications and conditions of use provided for in Article 7(2) of Regulation (EC) No 1332/20081 on food enzymes. Five applications have been introduced by the Association of manufacturers and formulators of enzyme products (AMFEP) for the authorisation of the food enzyme Bacillolysin from Bacillus subtilis and by the companies “Meiji Seika Pharma Co., Ltd” for the authorisation of the food enzyme Polygalacturonase from Talaromyces cellulolyticus/Talaromyces pinophilus, “Yakult Pharmaceutical Industry Co., Ltd.” for the authorisation of the food enzyme Beta‐galactosidase from Sporobolomyces singularis (YIT 10047), and “Bioresco Ltd.” for the authorisation of the food enzymes Cyclomaltodextrin glucanotransferase from a genetically modified strain of E.coli K12 (WCM105xpCM703) and Cyclomaltodextrin glucanotransferase from a genetically modified strain of E.coli K12 (WCM105xpCM6420). Following the requirements of Article 12.1 of Regulation (EC) No 234/2011 3 implementing Regulation (EC) No 1331/20082, the Commission has verified that the five applications fall within the scope of the food enzyme Regulation and contains all the elements required under Chapter II of that Regulation. Terms of Reference The European Commission requests the European Food Safety Authority to carry out the safety assessments on the food enzymes Bacillolysin from Bacillus subtilis, Polygalacturonase from Talaromyces cellulolyticus/Talaromyces pinophilus, Beta‐galactosidase from Sporobolomyces singularis (YIT 10047), Cyclomaltodextrin glucanotransferase from a genetically modified strain of E. coli K 12 (WCM105xpCM703) and Cyclomaltodextrin glucanotransferase from a genetically modified strain of E. coli K 12 (WCM105xpCM6420) in accordance with Article 17.3 of Regulation (EC) No 1332/20081 on food enzymes. Interpretation of the Terms of Reference The present scientific opinion addresses the European Commission's request to carry out the safety assessment of food enzyme bacillolysin from Bacillus subtilis submitted by the Association of manufacturers and formulators of enzyme products (AMFEP). The application was submitted initially as a joint dossier 4 and identified as the EFSA‐Q‐2016‐00527. Agreement to split the joint dossiers into individual data packages was made between EFSA, the European Commission and the Association of Manufacturers and Formulators of Enzyme Products (AMFEP). 5 The current opinion addresses one data package originating from the former joint dossier. This data package, identified as EFSA‐Q‐2022‐00517, concerns the food enzyme bacillolysin that is produced with Bacillus amyloliquefaciens strain BP and submitted by HBI Enzymes Inc. Recent data identified the production microorganism as B. amyloliquefaciens (Section 3.1). Therefore, this species name will be used in this opinion instead of B. subtilis. DATA AND METHODOLOGIES Data The applicant has submitted a dossier in support of the application for authorisation of the food enzyme bacillolysin from the non‐genetically modified B. amyloliquefaciens strain BP. Additional information, requested from the applicant during the assessment phase on 27 April 2023, 18 September 2023 and 28 June 2024, was received on 19 July 2023, 18 October 2023 and 8 July 2024, respectively (see ‘Documentation provided to EFSA’). Methodologies The assessment was conducted in line with the principles described in the EFSA ‘Guidance on transparency in the scientific aspects of risk assessment’ (EFSA, 2009) and following the relevant guidance documents of the EFSA Scientific Committee. The ‘Guidance on the submission of a dossier on food enzymes for safety evaluation’ (EFSA CEF Panel, 2009) as well as the ‘Statement on characterisation of microorganisms used for the production of food enzymes’ (EFSA CEP Panel, 2019) have been followed for the evaluation of the application. Additional information was requested in accordance with the updated ‘Scientific Guidance for the submission of dossiers on food enzymes’ (EFSA CEP Panel, 2021) and the guidance on the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). ASSESSMENT IUBMB nomenclatureBacillolysinSystematic name–Synonyms Bacillus metalloendopeptidase; Bacillus subtilis neutral proteinaseIUBMB NoEC 3.4.24.28CAS No9080‐56‐2EINECS No232‐991‐2 Bacillolysins catalyse the hydrolysis of the peptide bonds of proteins with broad specificity, releasing peptides and amino acids. The food enzyme under this assessment is intended to be used in eight food manufacturing processes as defined in the EFSA guidance (EFSA CEP Panel, 2023): (1) processing of dairy products for the production of modified milk proteins; (2) processing of meat and fish products for the production of protein hydrolysates from meat and fish; processing of cereals and other grains for the production of (3) baked products, (4) cereal‐based products other than baked, (5) brewed products and (6) distilled alcohol; (7) processing of plant‐ and fungal‐derived products for the production of protein hydrolysates from plants and fungi; (8) processing of yeast and yeast products. Source of the food enzyme The bacillolysin is produced with the non‐genetically modified bacterium B. amyloliquefaciens strain BP, which is deposited at the National Institute of Technology and Evaluation (NITE) Biological Resource Center (Japan), with the deposition number ■■■■■ 6 The production strain was identified as B. amyloliquefaciens by WGS analysis, showing an average nucleotide identity of 99.9% with the type strain ■■■■■. 7 The production strain is reported to derive from B. amyloliquefaciens strain ■■■■■ by classical mutagenesis and selection. The species B. amyloliquefaciens is included in the list of organisms for which the qualified presumption of safety (QPS) may be applied, provided that the absence of acquired antimicrobial resistance (AMR) genes and toxigenic activity are verified for the specific strain used (EFSA, 2007; EFSA BIOHAZ Panel, 2022). The production strain B. amyloliquefaciens BP was found not to be cytotoxic to CHO‐K1 cells using a lactate dehydrogenase assay. 8 The WGS of the production strain was interrogated for the presence of antimicrobial resistance genes using two databases with thresholds of > 80% identity and > 60% coverage. No genes of concern were found. 9 Therefore, the production strain is considered to qualify for the QPS approach. Production of the food enzyme The food enzyme is manufactured according to the Food Hygiene Regulation (EC) No 852/2004, 10 with food safety procedures based on Hazard Analysis and Critical Control Points and in accordance with Good Manufacturing Practice. 11 The production strain is grown as a pure culture using a typical industrial medium in a ■■■■■ fermentation system with conventional process controls in place. After completion of the fermentation, the solid biomass is removed from the fermentation broth by filtration. The filtrate containing the enzyme is then further purified and concentrated, including an ultrafiltration step in which enzyme protein is retained, while most of the low molecular mass material passes the membrane and is discarded. 12 The applicant provided information on the identity of the substances used to control the fermentation and in the subsequent downstream processing of the food enzyme. 13 The Panel considered that sufficient information has been provided on the manufacturing process and the quality assurance system implemented by the applicant to exclude issues of concern. Characteristics of the food enzyme Properties of the food enzyme The bacillolysin is composed of ■■■■■ amino acids and the molecular mass of the protein, calculated from the amino acid sequence, is ■■■■■ kDa. 14 The food enzyme was analysed by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis. 15 A consistent protein pattern was observed across all batches. The gel showed a major protein band migrating between the protein markers of ■■■■■ and ■■■■■ kDa in all batches, consistent with the expected mass of the mature enzyme. No other enzyme activities were reported. 16 The determination of bacillolysin activity is based on hydrolysis of ■■■■■ (reaction conditions: ■■■■■). The release of ■■■■■ is measured by means of a colorimetric reaction detected at ■■■■■ nm. The enzyme activity is expressed in Units (U)/g. One U is defined as the amount of enzyme that produces 1 μg of tyrosine equivalents per min under the assay conditions. 17 The food enzyme has a temperature optimum around 55°C (■■■■■) and a pH optimum around 7.5 (■■■■■). Thermostability was tested by pre‐incubation of the food enzyme for 15 min at different temperatures (■■■■■). Enzyme activity decreased above 40°C, showing no residual activity at 70°C. 18 Chemical parameters Data were provided for three batches of the food enzyme preparation intended for commercialisation and one additional batch used for toxicological studies (Table 1). 19 The mean total organic solids (TOS) of the three food enzyme batches intended for commercialisation was 5.8% and the mean enzyme activity/TOS ratio was 1963 U/mg TOS. TABLE 1Composition of the food enzyme preparation.ParametersUnitBatches1234 a Bacillolysin activity U/g b 104,000104,000105,000930,000 Protein %3.73.73.733.1 Ash %0.30.60.41.4 Water %35.237.734.56.0■■■■■ (excipient) %292929Not available■■■■■ (excipient) %292929Not available Total organic solids (TOS) c %6.53.77.1 Bacillolysin activity/TOS ratio U/mg TOS160028111479 a Batch used for the toxicological studies. b Unit: U/g (See Section 3.3.1). c TOS calculated as 100% – % water – % ash – % excipient. Composition of the food enzyme preparation. Batch used for the toxicological studies. Unit: U/g (See Section 3.3.1). TOS calculated as 100% – % water – % ash – % excipient. Purity The lead content in all batches was below 5 mg/kg 20 , 21 which complies with the specification for lead as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). The food enzyme preparation complies with the microbiological criteria for total coliforms, Escherichia coli and Salmonella as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). 22 No antimicrobial activity was detected in any of the tested batches. 23 The Panel considered that the information provided on the purity of the food enzyme was sufficient. Toxicological data The applicant provided a full battery of toxicological studies performed with batch 4 (Table 1), however, due to unknown content of diluents, the Panel is unable to calculate TOS content properly and establish the suitability of the test item. Therefore, these studies were not used in this assessment. The production strain qualifies for the QPS approach of safety assessment and no issue of concern arising from the production process of the food enzyme were identified (see Sections 3.1, 3.2 and 3.3), the Panel considered that no toxicological studies other than the assessment of allergenicity were necessary (EFSA CEP Panel, 2021). Allergenicity The allergenicity assessment considered only the food enzyme and not additives, carriers or other excipients that may be used in the final formulation. The potential allergenicity of the bacillolysin produced with the B. amyloliquefaciens strain BP was assessed by comparing its amino acid sequence with those of known allergens as described in the EFSA GMO Scientific Opinion (EFSA GMO Panel, 2010). Using higher than 35% identity in a sliding window of 80 amino acids as the criterion, a match with one respiratory allergen was found in the AllergenOnline database. 24 The matching respiratory allergen was Phl p 5, which has been suggested to be a ribonuclease‐like protein from timothy grass (Phleum pratenese). No reports on oral or respiratory sensitisation or elicitation reactions to the food enzyme under assessment have been published. Phl p 5 is a major allergen of Timothy grass pollen (Maglio et al., 2002). Timothy grass pollen allergens are involved in the pollen food allergy syndrome (Poncet et al., 2020). The pollen food allergy syndrome is typically restricted to the buccal cavity and rarely leads to severe allergy symptoms (Sarkar et al., 2018). No allergic reactions upon dietary exposure to any bacillolysin have been reported in the literature. 25 The Panel considered that the results of the sequence homology search and the available literature indicate a risk of allergic reactions for pollen‐allergic individuals upon dietary exposure to the food enzyme under assessment. ■■■■■ and ■■■■■, products from ■■■■■ and ■■■■■ that may cause allergies or intolerances (listed in the Regulation (EU) No 1169/2011 26 ), are used as raw materials. In addition, ■■■■■ and ■■■■■, known sources of allergens, are present in the culture medium. During the fermentation process, these products will mostly be degraded and utilised by the production strain. The Panel considered that residual amounts of allergenic proteins due to the raw material could be present in the food enzyme. Taking into account the level of dietary exposure (see Section 3.5), this would result in minute amounts in the final foods, from which allergic reactions are usually not expected. In conclusion, when used for the production of distilled alcohol, the Panel considered that a risk of allergic reactions upon dietary exposure can be excluded. For the remaining intended uses, the risk of allergic reactions upon dietary exposure to this food enzyme, particularly for pollen‐allergic individuals, cannot be excluded. Dietary exposure Intended use of the food enzyme The food enzyme is intended to be used in eight food manufacturing processes at the recommended use levels summarised in Table 2. TABLE 2Intended uses and recommended use levels of the food enzyme as provided by the applicant. 27 Food manufacturing process a Raw material (RM)Recommended use level (mg TOS/kg RM) b Processing of dairy products Production of modified milk proteins Whey proteins, caseins2.4–48 Processing of meat and fish products Production of protein hydrolysates from meat and fish proteins Meat and collagen 28 2.4–48 Processing of cereals and other grains Production of baked products Flour0.14–94.6 Production of cereal‐based products other than baked Cereals0.14–94.6 Production of brewed products Cereals2.37–47.3 Production of distilled alcohol Cereals2.37–47.3Processing of plant‐ and fungal‐derived products Production of protein hydrolysates from plants and fungi Soy protein 29 2.4–48 Processing of yeast and yeast productsYeast culture, yeast extract, yeast autolysate4.73–47.3 Abbreviation: TOS, total organic solids. a The name has been harmonised by EFSA according to the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). b The numbers in bold represent the maximum recommended use levels, which were used for calculation. Intended uses and recommended use levels of the food enzyme as provided by the applicant. 27 Production of modified milk proteins Production of modified milk proteins Production of protein hydrolysates from meat and fish proteins Production of protein hydrolysates from meat and fish proteins Production of baked products Production of baked products Production of cereal‐based products other than baked Production of cereal‐based products other than baked Production of brewed products Production of brewed products Production of distilled alcohol Production of distilled alcohol Production of protein hydrolysates from plants and fungi Production of protein hydrolysates from plants and fungi Abbreviation: TOS, total organic solids. The name has been harmonised by EFSA according to the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). The numbers in bold represent the maximum recommended use levels, which were used for calculation. In the production of modified milk proteins, the food enzyme is added to milk proteins 30 to improve solubility and taste. The food enzyme–TOS remains the modified milk proteins. In the production of protein hydrolysates, the food enzyme is added to a variety of protein‐rich materials from animal (e.g. meat, collagen) or plant (e.g. soy) 31 sources. The food enzyme–TOS remain in the protein hydrolysates. In the production of baked products and cereal‐based products other than baked, the food enzyme is added to flour during the preparation of the dough or batter 32 to catalyse the hydrolysis of gluten proteins, facilitating the handling of the dough. The food enzyme–TOS remains in the final foods. In the production of brewed products, the food enzyme is added to cereals during the mashing 33 to catalyse the release of free amino nitrogen for the growth of the yeast during fermentation. The food enzyme–TOS remains in the brewed products. In the production of distilled alcohol, the food enzyme may be added during the liquefaction and fermentation and may also be added during slurry mixing and saccharification 34 to improve the yield and to enhance the access of amylolytic enzymes to the starch granules, facilitating the degradation of starch and non‐starch polysaccharides into fermentable sugars. The food enzyme–TOS are not carried over into the distilled alcohol (EFSA CEP Panel, 2023). In the processing of yeast and yeast products, the food enzyme may be added to yeast during autolysis, directly to autolysed yeast or to yeast extracts 35 to intensify the savoury taste of the resulting yeast products, in which the food enzyme–TOS remains. Based on data provided on thermostability (see Section 3.3.1) and the downstream processing within the respective food manufacturing processes, the Panel considered that the food enzyme is inactivated in most of the food manufacturing processes listed in Table 2 in which the food enzyme–TOS remain. However, it may remain in its active form during the production of baked products, depending on the heat treatment conditions. Dietary exposure estimation In accordance with the guidance document (EFSA CEP Panel, 2021), a dietary exposure was calculated for the seven food manufacturing processes where the food enzyme–TOS remains in the final foods. Chronic exposure to the food enzyme–TOS was calculated by combining the maximum recommended use level with individual consumption data (EFSA CEP Panel, 2021). The estimation involved selection of relevant food categories and application of technical conversion factors (EFSA CEP Panel, 2023). Table 3 provides an overview of the derived exposure estimates across all surveys. Detailed mean and 95th percentile exposure to the food enzyme–TOS per age class, country and survey, as well as contribution from each FoodEx category to the total dietary exposure are reported in Appendix A – Tables 1 and 2. For the present assessment, food consumption data were available from 48 dietary surveys (covering infants, toddlers, children, adolescents, adults and the elderly), carried out in 26 European countries (Appendix B). The highest dietary exposure was estimated to be 1.249 mg TOS/kg bw per day in infants at the 95th percentile. TABLE 3Summary of the estimated dietary exposure to food enzyme–TOS in six population groups.Population groupEstimated exposure (mg TOS/kg body weight per day)InfantsToddlersChildrenAdolescentsAdultsThe elderly Age range 3–11 months12–35 months3–9 years10–17 years18–64 years≥ 65 years Min–max mean (number of surveys)0.104–0.495 (12)0.258–0.611 (15)0.114–0.538 (19)0.035–0.373 (21)0.121–0.240 (22)0.107–0.228 (23) Min–max 95th percentile (number of surveys)0.270–1.249 (11)0.552–1.047 (14)0.257–0.997 (19)0.087–0.643 (20)0.243–0.519 (22)0.215–0.430 (22)Abbreviation: TOS, total organic solids. Summary of the estimated dietary exposure to food enzyme–TOS in six population groups. Abbreviation: TOS, total organic solids. Uncertainty analysis In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, 2006), the following sources of uncertainties have been considered and are summarised in Table 4. TABLE 4Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate.Sources of uncertaintiesDirection of impact Model input data Consumption data: different methodologies/representativeness/underreporting/misreporting/no portion size standard+/−Use of data from food consumption surveys of a few days to estimate long‐term (chronic) exposure for high percentiles (95th percentile)+Possible national differences in categorisation and classification of food+/− Model assumptions and factors Exposure to food enzyme–TOS was always calculated based on the recommended maximum use level+For yeast processing, the food categories chosen for calculation are not only those containing yeast extract and autholised yeast 36 , but also those containing mannoproteins resulted from the treatment of yeast cell wall.+To estimate the exposure from the production of modified milk proteins, infant formulae, follow‐on formulae and food for special medical purposes are the only foods indicated by the applicant, 37 but the calculation included all the FoodEx categories that may contain modified milk proteins+Selection of broad FoodEx categories for the exposure assessment+Use of recipe fractions in disaggregation FoodEx categories+/−Use of technical factors in the exposure model+/−Exclusion of one process from the exposure assessment: – production of distilled alcohol− Note: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure. Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate. Note: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure. The conservative approach applied to estimate the dietary exposure to the food enzyme–TOS, in particular assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led to an overestimation of the exposure. The exclusion of one food manufacturing process from the exposure assessment was based on > 99% of TOS removal and is not expected to impact the overall estimate derived. Margin of exposure Since no toxicological assessment was considered necessary by the Panel, a margin of exposure was not calculated. CONCLUSIONS Based on the data provided, the QPS status of the production strain and the absence of issues of concern arising from the production process, the Panel concluded that the food enzyme bacillolysin produced with the non‐genetically modified B. amyloliquefaciens strain BP does not give rise to safety concerns under the intended conditions of use. DOCUMENTATION AS PROVIDED TO EFSA Application for authorisation of food enzyme bacillolysin from Bacillus amyloliquefaciens in accordance with Regulation (EC) No 1331/2008. August 2022. Submitted by HBI Enzymes Inc. Additional information. July 2023, October 2023 and July 2024. Submitted by HBI Enzymes Inc. ABBREVIATIONS antimicrobial resistance body weight Chemical Abstracts Service EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids EFSA Panel on Food Contact Materials, Enzymes and Processing Aids European Inventory of Existing Commercial Chemical Substances Food and Agricultural Organization of the United Nations good laboratory practice genetically modified microorganism genetically modified organism International Union of Biochemistry and Molecular Biology Joint FAO/WHO Expert Committee on Food Additives kiloDalton limit of detection bi‐nucleated cells with micronuclei margin of exposure Organisation for Economic Cooperation and Development polymerase chain reaction qualified presumption of safety sodium dodecyl sulfate‐polyacrylamide gel electrophoresis total organic solids whole genome sequencing World Health Organization REQUESTOR European Commission QUESTION NUMBER EFSA‐Q‐2022‐00517 COPYRIGHT FOR NON‐EFSA CONTENT EFSA may include images or other content for which it does not hold copyright. In such cases, EFSA indicates the copyright holder and users should seek permission to reproduce the content from the original source. PANEL MEMBERS José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize de Lourdes Marzo Solano, Henk Van Loveren, Laurence Vernis and Holger Zorn. LEGAL NOTICE The full opinion will be published in accordance with Article 12 of Regulation (EC) No 1331/2008 once the decision on confidentiality will be received from the European Commission. Supporting information APPENDIX A Dietary exposure estimates to the food enzyme–TOS in details Dietary exposure estimates to the food enzyme–TOS in details Appendix A can be found in the online version of this output (in the ‘Supporting information’ section). The file contains two sheets, corresponding to two tables. Table 1: Average and 95th percentile exposure to the food enzyme–TOS per age class, country and survey. Table 2: Contribution of food categories to the dietary exposure to the food enzyme–TOS per age class, country and survey. Population groups considered for the exposure assessment PopulationAge rangeCountries with food consumption surveys covering more than 1 day Infants From 12 weeks on up to and including 11 months of ageBulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Italy, Latvia, Portugal, Slovenia, Spain Toddlers From 12 months up to and including 35 months of ageBelgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Latvia, the Netherlands, Portugal, Republic of North Macedonia*, Serbia*, Slovenia, Spain Children From 36 months up to and including 9 years of ageAustria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, the Netherlands, Portugal, Republic of North Macedonia*, Serbia*, Spain, Sweden Adolescents From 10 years up to and including 17 years of ageAustria, Belgium, Bosnia and Herzegovina*, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Montenegro*, the Netherlands, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden Adults From 18 years up to and including 64 years of ageAustria, Belgium, Bosnia and Herzegovina*, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Montenegro*, the Netherlands, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden The elderly a From 65 years of age and olderAustria, Belgium, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Montenegro*, the Netherlands, Portugal, Romania, Serbia*, Slovenia, Spain, Sweden*Consumption data from these pre‐accession countries are not reported in Table 4 of this opinion, however, they are included in Appendix A for testing purpose. a The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’ in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 2011). Consumption data from these pre‐accession countries are not reported in Table 4 of this opinion, however, they are included in Appendix A for testing purpose. The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’ in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment’ (EFSA, 2011). EFSA FEZ Panel (EFSA Panel on Food Enzymes) , Zorn, H. , Barat Baviera, J. M. , Bolognesi, C. , Catania, F. , Gadermaier, G. , Greiner, R. , Mayo, B. , Mortensen, A. , Roos, Y. H. , Solano, M. L. M. , Van Loveren, H. , Vernis, L. , Lunardi, S. , Andryszkiewicz, M. , Cavanna, D. , Criado, A. , & Liu, Y. (2026). Safety evaluation of the food enzyme bacillolysin from the non‐genetically modified Bacillus amyloliquefaciens strain BP . EFSA Journal, 24(6), e10136. 10.2903/j.efsa.2026.10136 Adopted: 20 May 2026 Correspondence: Ask a Question The declarations of interest of all scientific experts active in EFSA's work are available at https://open.efsa.europa.eu/experts. Notes Regulation (EC) No 1332/2008 of the European Parliament and of the Council of 16 December 2008 on Food Enzymes and Amending Council Directive 83/417/EEC, Council Regulation (EC) No 1493/1999, Directive 2000/13/EC, Council Directive 2001/112/EC and Regulation (EC) No 258/97. OJ L 354, 31.12.2008, pp. 7–15. Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 354, 31.12.2008, pp. 1–6. Commission Regulation (EU) No 234/2011 of 10 March 2011 implementing Regulation (EC) No 1331/2008 of the European Parliament and of the Council establishing a common authorisation procedure for food additives, food enzymes and food flavourings. OJ L 64, 11.3.2011, pp. 15–24. Commission Implementing Regulation (EU) No 562/2012 of 27 June 2012 amending Commission Regulation (EU) No 234/2011 with regard to specific data required for risk assessment of food enzymes: Text with EEA relevance. OJ L 168, 28.6.2012, p. 21–23. The full detail is available at the https://www.efsa.europa.eu/en/events/event/ad‐hoc‐meeting‐industry‐association‐amfep‐joint‐dossiers‐food‐enzymes. Technical dossier/Annex T. Technical dossier/Additional data July 2023 and October 2023. Technical dossier/Annex N. Technical dossier/Additional data July 2023 and October 2023. Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of foodstuffs. OJ L 226, 25.6.2004, pp. 3–21. Technical dossier/p. 23, 28–30/Annex D. Technical dossier/pp. 23–30/Annex B1. Technical dossier/Additional data July 2023. Technical dossier/p. 33/Additional data July 2023/Additional data October 2023/Point 6. Technical dossier/p. 33–34. Technical dossier/p. 39. Technical dossier/Additional data July 2023/Annex G. Technical dossier/p. 38. Technical dossier/p. 36/Annexes: F, G, J1/Additional data July 2023/Table 7 Compositional data of the Bacillolysin preparation (Liquid product). Technical dossier/p. 37/Annexes: H, J2/Additional data July 2023/210506_Method_JECFA(microbio‐ecoli‐sallmonela‐lead‐antibioact) (002). LoQ: Pb = 0.05 mg/kg. Technical dossier/p. 37/Annexes: H, J2. Technical dossier/p. 37/Annexes: H, J2. Technical dossier/pp. 41–44/Annex K1/Additional data July 2023/Additional data October 2023/Point 6. Technical dossier/pp. 43–45 and Additional data July 2023. Regulation (EU) No 1169/2011 of the European Parliament and of the Council of 25 October 2011 on the provision of food information to consumers, amending Regulations (EC) No 1924/2006 and (EC) No 1925/2006 of the European Parliament and of the Council, and repealing Commission Directive 87/250/EEC, Council Directive 90/496/EEC, Commission Directive 1999/10/EC, Directive 2000/13/EC of the European Parliament and of the Council, Commission Directives 2002/67/EC and 2008/5/EC and Commission Regulation (EC) No 608/2004. Additional data October 2023/Table 8. Additional data October 2023/Answer to point 13b. Additional data October 2023/Answer to point 13b. Technical dossier/p. 54. Additional data October 2023/ Answer to point 13b. Additional data October 2023/Answer to point 11. Technical dossier/p. 48. Technical dossier/p. 49. Technical dossier/p. 51. Additional data October 2023/p. 9. Additional data October 2023/p. 17. REFERENCES Associated Data Supplementary Materials APPENDIX A Dietary exposure estimates to the food enzyme–TOS in details